跳转至内容
Merck
  • TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes.

TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes.

Cell reports (2021-08-26)
Gregory W Schwartz, Yeqiao Zhou, Jelena Petrovic, Warren S Pear, Robert B Faryabi
摘要

Emerging single-cell epigenomic assays are used to investigate the heterogeneity of chromatin activity and its function. However, identifying cells with distinct regulatory elements and clearly visualizing their relationships remains challenging. To this end, we introduce TooManyPeaks to address the need for the simultaneous study of chromatin state heterogeneity in both rare and abundant subpopulations. Our analyses of existing data from three widely used single-cell assays for transposase-accessible chromatin using sequencing (scATAC-seq) show the superior performance of TooManyPeaks in delineating and visualizing pure clusters of rare and abundant subpopulations. Furthermore, the application of TooManyPeaks to new scATAC-seq data from drug-naive and drug-resistant leukemic T cells clearly visualizes relationships among these cells and stratifies a rare "resistant-like" drug-naive sub-clone with distinct cis-regulatory elements.

材料
货号
品牌
产品描述

Sigma-Aldrich
2-巯基乙醇, ≥99.0%
Sigma-Aldrich
γ-分泌酶抑制剂XXI,化合物E, This g-secretase inhibitor, CAS 209986-17-4, is a cell-permeable, potent, selective, non-transition-state analog inhibitor of γ-secretase and Notch processing. Lowers Aβ levels in APP transgenic mice